• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number PAH101002E
Device Problem Complete Blockage (1094)
Patient Problem Occlusion (1984)
Event Date 01/10/2019
Event Type  Injury  
Manufacturer Narrative
Date the incident occurred is unknown.Therefore the date on which the presentation was sent to gore for review was used as the date of event.The reported occlusion of the reported gore® excluder® iliac branch endoprostheses (ibe)for patient 003-011 will be reported in gore event 40643.
 
Event Description
A presentation with the title ¿bilateral use of the gore ibe device for bilateral cia aneurysms and a first interim analysis of the prospective iceberg registry¿ was held by (b)(6) at the linc convention on (b)(6) 2019.The presentation included initial results of the ongoing iceberg study that included 101 patients at eight international sites that were treated with gore® excluder® aaa endoprostheses and gore® excluder® iliac branch endoprostheses (ibe).Among other occurrences, the presentation mentions 4 early occlusions of the hypogastric branch.Additional details were not provided.The following additional info was reported to gore on may 3, 2019: (b)(6) presented with thrombosis of the ibe internal iliac component (hgb) and in addition two gore® viabahn® endoprostheses (pah), which was identified within 30 days from the implant procedure.It was stated that the patient was asymptomatic.Additionally it was reported that the hgb was extended with a pah into the internal iliac artery.An intra-procedure type iii endoleak between the two devices was solved with the implantation of a second pah.The physician assumes that the tortuosity of the vessel, the overlap of the grafts and the overlap of the devices caused excessive stiffness of the system and contributed to the occlusion.
 
Manufacturer Narrative
A2/3: the patient age and patient gender reflects the mean age and gender stated in the presentation.B3: the physician requested review on (b)(6) 2019.B5: the reported occlusion of the reported gore® excluder® iliac branch endoprostheses (ibe)for patient (b)(6) will be reported in event (b)(4) (mfr report# 2953161-2019-00041).G5: corrected combination product to yes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8626665
MDR Text Key145614551
Report Number2017233-2019-00362
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P130006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup
Report Date 09/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/21/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/29/2019
Device Catalogue NumberPAH101002E
Device Lot Number15528518
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age70 YR
-
-